|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received February 8, 2007
Revised March 7, 2007
Accepted after revision March 11, 2007
1 The University of Chicago
* To whom correspondence should be addressed. E-mail: hafozzar{at}uchicago.edu.
Our homology molecular model of the open/inactivated state of the Na+ channel pore predicts, based on extensive mutagenesis data, that the local anesthetic lidocaine docks eccentrically below the selectivity filter, such that physical occlusion is incomplete. Electrostatic field calculations suggest that the drugs positively charged amine produces an electrostatic barrier to permeation. To test the effect of charge at this pore level on permeation in hNaV1.5 we replaced Phe-1759 of domain IVS6, the putative binding site for lidocaines alkylamino end, with positively and negatively charged residues as well as the neutral cysteine and alanine. These mutations eliminated use-dependent lidocaine block with no effect on tonic/rested state block. Mutant whole cell currents were kinetically similar to wild type (WT). Single channel conductance (
) was reduced from WT in both F1759K (by 38%) and F1759R (by 18%). The negatively charged mutant F1759E increased
by 14%, as expected if the charge effect were electrostatic, although F1759D was like WT. None of the charged mutations affected Na/K selectivity. Calculation of difference electrostatic fields in the pore model predicted that lidocaine produced the largest positive electrostatic barrier, followed by lysine and arginine, respectively. Negatively charged glutamate and aspartate both lowered the barrier, with glutamate being more effective. Experimental data were in rank order agreement with the predicted changes in the energy profile. These results demonstrate that permeation rate is sensitive to the inner pore electrostatic field, and they are consistent with creation of an electrostatic barrier to ion permeation by lidocaines charge.
Related Article
This article has been cited by other articles:
![]() |
I. Bruhova, D. B. Tikhonov, and B. S. Zhorov Access and Binding of Local Anesthetics in the Closed Sodium Channel Mol. Pharmacol., October 1, 2008; 74(4): 1033 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Fozzard Increased Sensitivity to Local Anesthetic Drugs: Bedside to Bench Circ. Res., August 15, 2008; 103(4): 325 - 327. [Full Text] [PDF] |
||||
![]() |
G. M. Lipkind and H. A. Fozzard Voltage-gated Na Channel Selectivity: The Role of the Conserved Domain III Lysine Residue J. Gen. Physiol., May 26, 2008; 131(6): 523 - 529. [Full Text] [PDF] |
||||
![]() |
G. K. Wang, J. Calderon, and S.-Y. Wang State- and Use-Dependent Block of Muscle Nav1.4 and Neuronal Nav1.7 Voltage-Gated Na+ Channel Isoforms by Ranolazine Mol. Pharmacol., March 1, 2008; 73(3): 940 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Ahern, A. L. Eastwood, D. A. Dougherty, and R. Horn Electrostatic Contributions of Aromatic Residues in the Local Anesthetic Receptor of Voltage-Gated Sodium Channels Circ. Res., January 4, 2008; 102(1): 86 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R Cummins Setting up for the block: the mechanism underlying lidocaine's use-dependent inhibition of sodium channels J. Physiol., July 1, 2007; 582(1): 11 - 11. [Full Text] [PDF] |
||||
![]() |
M. F. Sheets and D. A. Hanck Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels J. Physiol., July 1, 2007; 582(1): 317 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Scheuer Local anaesthetic block of sodium channels: raising the barrier J. Physiol., June 1, 2007; 581(2): 423 - 423. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |